LET’S MAKE SARCOMA HISTORY
In 2020 the Australian Institute of Health and Welfare (AIHW) predicted bone and soft tissue cancers combined would be the leading cause of cancer related death in the 10-24 year age group in Australia.
Funding for sarcoma specific clinical research holds the key to critical change.
Meet the IL-23 Sarcoma Sub-Study Team

CRBF is very proud to be a major funder of the IL23 sarcoma sub study, together with the Matthew Fisher Sarcoma Research Fund, The Daniel Allchin Race for a cure, The Kids Cancer Project, the NSW and Federal Governments, and Sun Pharma.
We are humbled by the support and generosity of those who have contributed to making this trial a reality.

The work of CRBF is proudly supported by the Weinert Group of Companies and the generosity of the Weinert family